Boston Trust Walden Corp Sells 188 Shares of McKesson Corporation $MCK

Boston Trust Walden Corp decreased its holdings in McKesson Corporation (NYSE:MCK) by 10.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,607 shares of the company’s stock after selling 188 shares during the quarter. Boston Trust Walden Corp’s holdings in McKesson were worth $1,178,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in MCK. Brighton Jones LLC boosted its holdings in shares of McKesson by 46.3% in the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after buying an additional 798 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of McKesson by 12.5% in the first quarter. GAMMA Investing LLC now owns 3,556 shares of the company’s stock worth $2,393,000 after buying an additional 396 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of McKesson by 4.3% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 183,258 shares of the company’s stock worth $123,332,000 after buying an additional 7,556 shares during the last quarter. Dynamic Advisor Solutions LLC raised its stake in shares of McKesson by 16.6% in the first quarter. Dynamic Advisor Solutions LLC now owns 778 shares of the company’s stock worth $524,000 after buying an additional 111 shares during the period. Finally, Janney Montgomery Scott LLC raised its stake in shares of McKesson by 5.7% in the first quarter. Janney Montgomery Scott LLC now owns 46,811 shares of the company’s stock worth $31,503,000 after buying an additional 2,508 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling at McKesson

In other news, CEO Brian S. Tyler sold 11,930 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $705.63, for a total transaction of $8,418,165.90. Following the transaction, the chief executive officer owned 4,012 shares of the company’s stock, valued at approximately $2,830,987.56. This represents a 74.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the stock in a transaction on Friday, August 8th. The stock was sold at an average price of $663.67, for a total value of $218,347.43. Following the transaction, the chief accounting officer directly owned 657 shares in the company, valued at $436,031.19. The trade was a 33.37% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 24,189 shares of company stock valued at $16,722,190 over the last quarter. Company insiders own 0.08% of the company’s stock.

McKesson Price Performance

Shares of NYSE MCK opened at $791.40 on Thursday. The company has a market cap of $98.43 billion, a P/E ratio of 31.55, a PEG ratio of 1.41 and a beta of 0.52. McKesson Corporation has a 1 year low of $492.39 and a 1 year high of $792.34. The firm has a 50-day simple moving average of $711.83 and a two-hundred day simple moving average of $708.47.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $8.26 EPS for the quarter, missing the consensus estimate of $8.33 by ($0.07). The company had revenue of $97.83 billion during the quarter, compared to analysts’ expectations of $95.93 billion. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The company’s quarterly revenue was up 23.4% on a year-over-year basis. During the same period in the prior year, the business earned $7.88 EPS. As a group, equities research analysts expect that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 1st. Investors of record on Tuesday, September 2nd were paid a $0.82 dividend. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. This is a boost from McKesson’s previous quarterly dividend of $0.71. McKesson’s payout ratio is 13.08%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on MCK shares. Weiss Ratings reiterated a “buy (b)” rating on shares of McKesson in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft increased their price target on McKesson from $775.00 to $856.00 and gave the stock a “buy” rating in a research note on Wednesday, September 24th. Cowen reiterated a “buy” rating on shares of McKesson in a research note on Wednesday, September 24th. TD Cowen increased their price target on McKesson from $830.00 to $864.00 and gave the stock a “buy” rating in a research note on Wednesday, September 24th. Finally, UBS Group increased their price target on McKesson from $820.00 to $860.00 and gave the stock a “buy” rating in a research note on Wednesday, September 24th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $834.54.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.